Introduction
In 1961 Sipple described a relationship between carcinoma of the thyroid and phaeochromocytoma (Sipple 1961) . The familial syndrome of medullary carcinoma of thyroid and phaeochromocytoma with, less often, parathyroid hyperplasia or mucosal neuroma, is now established and is known as multiple endocrine adenomatosis type II or MEA II (Block et al. 1975) .
Although a number of such families have been previously reported, this family has been documented not only because of the rarity of the syndrome but because it illustrates some unusual features and demonstrates the consequences offailing to establish its genetic nature.
Family history J B, a 46-year-old woman, consulted her general practitioner in Mansfield, Nottinghamshire in 1971, because she was concerned that all 3 of her elder sisters had died from bilateral phaeochromocytomas; she wanted reassurance that she was not going to be the next.
On review, the family history (see Figure 1 ) began eleven years earlier in 1960, in Chesterfield, Derbyshire, when N D, the eldest sister, died suddenly and unexpectedly at the age of 36. Post-mortem examination showed bilateral phaeochromocytomas with hepatic secondaries.
Three years later, in 1963, also in Chesterfield, the second sister H W, then aged 35 years, died suddenly and unexpectedly during her third normal pregnancy. Post-mortem again showed bilateral phaeochromocytomas and also medullary carcinoma of the thyroid. She had had an untreated goitre for many years.
Eight years later, in 1971, this time in Mansfield, the third sister K D, then aged 44 years, died suddenly and unexpectedly. Post-mortem examination again showed bilateral phaeochromocytomas.
It was this last death that led J B to seek advice in 1971.Screening by urinary catecholamine excretion for phaeochromocytoma and plasma calcitonin for medullary carcinoma were negative. She does, however, have a nodule on her right eyelid which may represent a mucosal neuroma and is awaiting biopsy.
Four years later in 1975, the last and youngest sister, M B, then aged 37 years, consulted her general practitioner in Alfreton, Derbyshire complaining of palpitations. Urinary catecholamine excretion was elevated and bilateral phaeochromocytomas were successfully removed in Sheffield. Plasma calcitonin levels, which were tested in order to exclude medullary carcinoma of thyroid, have so far not been elevated.
Meanwhile, in 1974,K W, then 24 years ofage, consulted his general practioner in Mansfield complaining of diarrhoea with blood and mucus. He was thought to have ulcerative colitis. It was later realized that he was the younger son of H W who had died eleven years previously with bilateral phaeochromocytomas and medullary carcinoma of thyroid. Incidental diffuse thyroid enlargement with bilateral cervical lymphadenopathy was noted and lymph node biopsy showed metastatic medullary carcinoma of the thyroid. Plasma calcitonin was grossly elevated at 23000 pg/ml (normal < 100 pg/ml), Near total thyroidectomy with right block dissection of neck and deep X-ray therapy to his left neck was performed. He still has residual tumour and diarrhoea today.
The remaining members of the family are now being screened by regular catecholamine excretion and calcitonin assay, as recommended by Melvin et al. (1972) . 
Discussion
The relationship between these seemingly diverse tumours is now established. Histologically, the cells of origin of medullary carcinoma of thyroid (the parafollicular or C cell producing calcitonin) and phaeochromocytoma (the adrenal medulla) have a similar clear cell pattern (Williams 1975) . However, when medullary carcinoma arises, its histological appearance can be variable and clear cells are often not present. One appearance (Figure 2) , a thyroid specimen from K W, shows sheets of cells forming neither follicles nor papillae with a mass of amyloid which is present in the majority of these tumours.
Embryologically, the cells of origin are derived from the neural crest (neuroectoderm), in the case of the parafollicular cells reaching the thyroid via the ultimobranchial body (Williams 1975) .They are also cytochemically similar, the cells oforigin being capable ofamine precursor uptake and decarboxylation (APUD) (Pearse 1968 (Pearse , 1969 .
The familial nature of these related tumours and their bilateral or multicentric occurrences shown by this family suggests a genetically determined neuroectodermal cell dysplasia. Inheritance is by autosomal dominant with a high degree of penetrance meaning up to half of the offspring of affected parents married to normals will be affected (Melvin et al. 1972) . In this family 4 (and possibly 5) out of 5 in the second generation and, so far, one out of 8 in the third generation have been affected. This large proportion of affected individuals in the second generation is probably the result ofchance, as the probability ofall 5 being affected is similar to that of them all being of the same sex. The origin of the gene in the apparently unaffected first generation is as yet not established and investigation of them and of the cause of sudden death in other siblings of both families of the first generation is in progress.
The genetic defect may manifest itself in various forms (genetic pleiotropism). Three members of this family had bilateral phaeochromocytoma, one had medullary carcinoma and one had both. Even though these numbers are small, phaeocbromocytoma does seem more common than in Ljunberg's series; he noted that in affected members offamilies, half had both medullary carcinoma and phaeochromocytoma and the remaining half had one tumour or the other (Ljungberg 1972).The late manifestation ofthe genetic defect (abiotrophy) in this family, between 24 years and 44 years of age, is similar to the age range in other reported series. However, presentation of medullary carcinoma in patient K W at 24 years of age is earlier than the usual minimum age of 30 years as reported by Williams (Williams 1975) . This suggests a more aggressive form of the syndrome in this patient. It is this late and unexpected presentation, usually after the onset of the reproductive period as shown in this family, that has important implications in the follow up of these families.
The presentation of the syndrome depends on the clinical form (phenotype) that the genetic abnormality (genotype) takes. Of the 4 patients in this family presenting with phaeochromocytoma, 3 were undiagnosed during life. The first sister N D had a subtotal thyroidectomy for thyrotoxicosis in 1951. When she was examined in 1956 she was suffering from polymenorrhagia, headaches, nervousness and irritability, and her blood pressure was recorded at 180/115, pulse at 115 per minute, but there were no eye signs present. Without the benefit, at that time, of biochemical investigations, she was diagnosed and treated for recurrent thyrotoxicosis. Five years later in 1961 she died suddenly. Post-mortem examination showed hepatic secondaries from her phaeochromocytomas. In his series Ljungberg found no metastatic spread or other evidence of malignancy (Ljungberg 1972) .
In contrast, the second sister H W, the mother of K W, who died aged 35 years during her third pregnancy, was completely asymptomatic. Her only abnormality was an enlarged thyroid, present for 5-10 years, a not uncommon condition in the region. The third sister K D suffered only from episodic headaches and the day prior to her sudden death had suffered a headache of more than usual intensity. The last sister M B who had her phaeochromocytoma successfully removed, complained only of episodic palpitations and reported these to her doctor only because she was aware of the family history. There is therefore, in this family, a spectrum of presentation of phaeochromocytoma from being completely asymptomatic before sudden death to long duration of symptoms with the development of hepatic secondaries.
Conclusion
An MEA type II family has been presented. The variable and unpredictable progression of phaeochromocytoma to sudden death and the unusual development of hepatic secondaries is shown. The death of 3 patients and the presence of an inoperable carcinoma in another demonstrates the consequences of failing to recognize its familial nature.
